Kuguacin R is a cucurbitane-type triterpenoid isolated from the tubers of *Momordica charantia* (bitter melon). It is a natural product characterized by a complex polycyclic structure typical of cucurbitacins, which are known for their diverse biological activities. Extensive research has focused on its potent anti-cancer properties. Studies have demonstrated that Kuguacin R exhibits significant cytotoxic effects against various human cancer cell lines, including breast cancer (MCF-7), liver cancer (HepG2), and lung cancer (A549). Its mechanisms of action are multifaceted, involving the induction of apoptosis (programmed cell death), cell cycle arrest, and inhibition of cancer cell migration and invasion. These properties position it as a promising lead compound for the development of novel anti-tumor agents. As a bioactive natural product, Kuguacin R serves as a valuable tool in pharmacological research for studying cancer biology and exploring new therapeutic pathways. Its isolation and characterization contribute to the understanding of the medicinal value of traditional plants.